<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="courier ; font-style : italic;} Infect Dis PovertyInfect Dis PovertyInfectious" exact="Diseases" post="of Poverty2095-51622049-9957BioMed CentralLondon pmcid: 7369569691 doi: 10.1186/s40249-020-00691-6 : Scoping"/>
 <result pre="grid.216417.70000 0001 0379 7164Department of Pediatrics, The Third Xiangya Hospital," exact="Central" post="South University, [2], grid.216417.70000 0001 0379 7164Xiangya School of"/>
 <result pre="South University, [2], grid.216417.70000 0001 0379 7164Xiangya School of Medicine," exact="Central" post="South University, [3], epub: 2020-7-7pmc-release: 2020-7-7collection: 2020999received: 2020-2-12accepted: 2020-6-9(C)"/>
 <result pre="line to the data. Abstract Background The outbreak of coronavirus" exact="disease" post="2019 (COVID-19) has caused a public catastrophe and global"/>
 <result pre="main symptoms of COVID-19 are fever, cough, myalgia, fatigue and" exact="lower" post="respiratory tract infection signs. Almost all populations are susceptible"/>
 <result pre="symptoms of COVID-19 are fever, cough, myalgia, fatigue and lower" exact="respiratory" post="tract infection signs. Almost all populations are susceptible to"/>
 <result pre="COVID-19 are fever, cough, myalgia, fatigue and lower respiratory tract" exact="infection" post="signs. Almost all populations are susceptible to the virus,"/>
 <result pre="treatment, antiviral treatment, and oxygen therapy. For patients with severe" exact="acute" post="respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) and"/>
 <result pre="antiviral treatment, and oxygen therapy. For patients with severe acute" exact="respiratory" post="distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO) and circulatory"/>
 <result pre="and oxygen therapy. For patients with severe acute respiratory distress" exact="syndrome" post="(ARDS), extracorporeal membrane oxygenation (ECMO) and circulatory support are"/>
 <result pre="similarities and differences between COVID-19 and previous outbreaks of severe" exact="acute" post="respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS)"/>
 <result pre="and differences between COVID-19 and previous outbreaks of severe acute" exact="respiratory" post="syndrome (SARS) and Middle East respiratory syndrome (MERS) and"/>
 <result pre="differences between COVID-19 and previous outbreaks of severe acute respiratory" exact="syndrome" post="(SARS) and Middle East respiratory syndrome (MERS) and to"/>
 <result pre="outbreaks of severe acute respiratory syndrome (SARS) and Middle East" exact="respiratory" post="syndrome (MERS) and to provide guidance regarding new methods"/>
 <result pre="of severe acute respiratory syndrome (SARS) and Middle East respiratory" exact="syndrome" post="(MERS) and to provide guidance regarding new methods of"/>
 <result pre="COVID-19 Coronavirus SARS MERS Autodock Background The outbreak of coronavirus" exact="disease" post="2019 (COVID-19) caused by a novel coronavirus has become"/>
 <result pre="emergency of international concern (PHEIC). The virus can cause severe" exact="respiratory" post="disease and can spread from person to person. The"/>
 <result pre="of international concern (PHEIC). The virus can cause severe respiratory" exact="disease" post="and can spread from person to person. The virus"/>
 <result pre="from person to person. The virus has been named severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) based on its appearance"/>
 <result pre="person to person. The virus has been named severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) based on its appearance under"/>
 <result pre="to person. The virus has been named severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) based on its appearance under electron"/>
 <result pre="Emergency of International Concern (PHIEC) [2]. The Chinese Center for" exact="Disease" post="Control and Prevention (China CDC) determined that SARS-CoV-2 infection"/>
 <result pre="for Disease Control and Prevention (China CDC) determined that SARS-CoV-2" exact="infection" post="is the cause of the outbreak that started in"/>
 <result pre="Wuhan City (CDC, 2020) [3]. The virus can cause severe" exact="respiratory" post="illness, and human to human transmission has been confirmed"/>
 <result pre="illness, and human to human transmission has been confirmed [4]." exact="Isolated" post="viruses were observed under electron microscopy and named SARS-CoV-2"/>
 <result pre="Î², Î³ and Î´. There are six coronaviruses that cause" exact="disease" post="in humans, including 229E and NL63 of the Î±"/>
 <result pre="MERS-CoV of the Î² genus [1, 6â€&quot;8]. Human coronavirus (hCoV)" exact="infection" post="is mainly related to the respiratory, intestinal and nervous"/>
 <result pre="nervous systems. In 2002â€&quot;2003, SARS-CoV caused an epidemic of severe" exact="acute" post="respiratory diseases in China; MERS-CoV was found in the"/>
 <result pre="systems. In 2002â€&quot;2003, SARS-CoV caused an epidemic of severe acute" exact="respiratory" post="diseases in China; MERS-CoV was found in the Middle"/>
 <result pre="of these coronaviruses are zoonotic pathogens that can cause severe" exact="respiratory" post="disease in humans, which can progress to severe acute"/>
 <result pre="these coronaviruses are zoonotic pathogens that can cause severe respiratory" exact="disease" post="in humans, which can progress to severe acute respiratory"/>
 <result pre="severe respiratory disease in humans, which can progress to severe" exact="acute" post="respiratory distress syndrome. According to the experiment by Peng"/>
 <result pre="respiratory disease in humans, which can progress to severe acute" exact="respiratory" post="distress syndrome. According to the experiment by Peng et"/>
 <result pre="as a cellular entry receptor; ACE2 is distributed on the" exact="epithelial" post="cells of the alveoli, trachea, bronchi, serous bronchial glands,"/>
 <result pre="distributed on the epithelial cells of the alveoli, trachea, bronchi," exact="serous" post="bronchial glands, alveolar monocytes and macrophages in the respiratory"/>
 <result pre="bronchi, serous bronchial glands, alveolar monocytes and macrophages in the" exact="respiratory" post="tract. ACE2 is also widely expressed on the mucosa,"/>
 <result pre="and fatigue Susceptible population All people All people (a slight" exact="female" post="predominance) All people (predominantly older males) Respiratory tract symptoms"/>
 <result pre="people (a slight female predominance) All people (predominantly older males)" exact="Respiratory" post="tract symptoms Pneumonia and lower respiratory signs Upper respiratory"/>
 <result pre="female predominance) All people (predominantly older males) Respiratory tract symptoms" exact="Pneumonia" post="and lower respiratory signs Upper respiratory signs and gastrointestinal"/>
 <result pre="All people (predominantly older males) Respiratory tract symptoms Pneumonia and" exact="lower" post="respiratory signs Upper respiratory signs and gastrointestinal symptoms Upper"/>
 <result pre="people (predominantly older males) Respiratory tract symptoms Pneumonia and lower" exact="respiratory" post="signs Upper respiratory signs and gastrointestinal symptoms Upper respiratory"/>
 <result pre="males) Respiratory tract symptoms Pneumonia and lower respiratory signs Upper" exact="respiratory" post="signs and gastrointestinal symptoms Upper respiratory signs and gastrointestinal"/>
 <result pre="lower respiratory signs Upper respiratory signs and gastrointestinal symptoms Upper" exact="respiratory" post="signs and gastrointestinal symptoms Receptor ACE2 ACE2 hDPP4 Intermediary"/>
 <result pre="Arabian Peninsula Route transmission Airway, contact transmission and aerosol transmission" exact="Respiratory" post="droplets transmission or direct person-to-person transmission through close contact"/>
 <result pre="virus to have a coronal shape. According to the virus" exact="morphology" post="observed under the microscope, the virus is consistent with"/>
 <result pre="susceptible, and the spike protein initiates the merging of the" exact="viral" post="envelope with the host cell cytomembrane. Existing experimental studies"/>
 <result pre="fatigue. Almost all of the patients have pneumonia, and their" exact="chest" post="CT examinations are abnormal [1, 4, 15â€&quot;17]. However, those"/>
 <result pre="However, those who are infected with SARS-CoV-2 rarely have significant" exact="upper" post="respiratory signs and symptoms, including nosebleed, sneezing or sore"/>
 <result pre="those who are infected with SARS-CoV-2 rarely have significant upper" exact="respiratory" post="signs and symptoms, including nosebleed, sneezing or sore throat,"/>
 <result pre="which indicates that the target cell may exist in the" exact="lower" post="respiratory tract. This is consistent with the autopsy reports"/>
 <result pre="indicates that the target cell may exist in the lower" exact="respiratory" post="tract. This is consistent with the autopsy reports of"/>
 <result pre="autopsy reports of patients with COVID-19 that show that SARS-CoV-2" exact="infection" post="mainly causes deep airway inflammatory reactions and alveolar damage."/>
 <result pre="are less likely to have gastrointestinal symptoms [4]. Complications include" exact="acute" post="respiratory distress syndrome, acute heart injury, and secondary infections."/>
 <result pre="less likely to have gastrointestinal symptoms [4]. Complications include acute" exact="respiratory" post="distress syndrome, acute heart injury, and secondary infections. COVID-19"/>
 <result pre="have gastrointestinal symptoms [4]. Complications include acute respiratory distress syndrome," exact="acute" post="heart injury, and secondary infections. COVID-19 patients can be"/>
 <result pre="gastrointestinal symptoms [4]. Complications include acute respiratory distress syndrome, acute" exact="heart" post="injury, and secondary infections. COVID-19 patients can be divided"/>
 <result pre="Complications include acute respiratory distress syndrome, acute heart injury, and" exact="secondary" post="infections. COVID-19 patients can be divided into those with"/>
 <result pre="the lowest fatality rate. It is worth noting that watery" exact="diarrhea" post="is common in almost 60% of patients who suffer"/>
 <result pre="patients who suffer from SARS, and there is a typical" exact="biphasic" post="clinical course [10, 18, 19]. In MERS, most patients"/>
 <result pre="the lesions caused by SARS, revealing that in COVID-19, the" exact="chest" post="lesions are not primarily serous inflammation but rather are"/>
 <result pre="revealing that in COVID-19, the chest lesions are not primarily" exact="serous" post="inflammation but rather are exudative reactions. Whether damage to"/>
 <result pre="chest lesions are not primarily serous inflammation but rather are" exact="exudative" post="reactions. Whether damage to the brain, myocardium, epicardium, kidneys,"/>
 <result pre="myocardium, epicardium, kidneys, spleen and digestive organs is associated with" exact="viral infection" post="needs further research. Identification and diagnosis Next-generation sequencing (NGS)"/>
 <result pre="epicardium, kidneys, spleen and digestive organs is associated with viral" exact="infection" post="needs further research. Identification and diagnosis Next-generation sequencing (NGS)"/>
 <result pre="lesions show characteristic (1) distribution (mainly subpleural, along the bronchial" exact="vascular" post="bundles); (2) quantity (often more than three lesions, occasionally"/>
 <result pre="wall, etc.); and (5) concomitant signs (e.g., air bronchogram, rare" exact="pleural" post="effusion and mediastinal lymph node enlargement). However, these are"/>
 <result pre="that cause pneumonia, such as influenza virus, parainfluenza virus, adenovirus," exact="respiratory" post="syncytial virus, rhinovirus, human metapneumovirus, SARS-CoV, etc. and from"/>
 <result pre="respiratory syncytial virus, rhinovirus, human metapneumovirus, SARS-CoV, etc. and from" exact="Mycoplasma pneumonia," post="Chlamydia pneumonia, and bacterial pneumonia. In addition, COVID-19 should"/>
 <result pre="virus, rhinovirus, human metapneumovirus, SARS-CoV, etc. and from Mycoplasma pneumonia," exact="Chlamydia pneumonia," post="and bacterial pneumonia. In addition, COVID-19 should be distinguished"/>
 <result pre="metapneumovirus, SARS-CoV, etc. and from Mycoplasma pneumonia, Chlamydia pneumonia, and" exact="bacterial pneumonia." post="In addition, COVID-19 should be distinguished from noninfectious diseases,"/>
 <result pre="mRNA vaccine platforms109. On 23 January 2020, The Coalition for" exact="Epidemic" post="Preparedness Innovations (CEPI) announced that they will fund vaccine"/>
 <result pre="funded by CEPI. For SARS, the vaccines in development include" exact="viral" post="vector-based vaccines, DNA vaccines, subunit vaccines, virus-like particle (VLP)-based"/>
 <result pre="trial conducted by the US National Institute of Allergy and" exact="Infectious" post="Diseases. Both Phase I clinical trials reported positive results,"/>
 <result pre="(M1, M3) receptor anticholinergic drugs for dyspnea, coughing, wheezing, and" exact="respiratory" post="distress syndrome. Although Î±-interferon atomization inhalation and oral lopinavir/ritonavir"/>
 <result pre="and critically ill patients, as classified according to the guidelines." exact="Isolated" post="patients at home should monitor their body temperature and"/>
 <result pre="a nasal catheter or a mask, antiviral drugs, antibacterial drugs," exact="symptomatic" post="treatments, nutritional support and psychological counselling. Critically ill patients"/>
 <result pre="in Wuhan, China. Critically ill patients died of severe pneumonia," exact="septic shock," post="respiratory failure and multiple organ failure (MOF). The authors"/>
 <result pre="China. Critically ill patients died of severe pneumonia, septic shock," exact="respiratory" post="failure and multiple organ failure (MOF). The authors reached"/>
 <result pre="speculative conclusion that SARS-CoV-2 is more likely to infect older" exact="adult" post="males with chronic comorbidities as a result of their"/>
 <result pre="SARS-CoV-2 is more likely to infect older adult males with" exact="chronic" post="comorbidities as a result of their weaker immune systems."/>
 <result pre="with increased mortality. In addition, a substantial decrease in the" exact="total" post="number of lymphocytes indicates that SARS-CoV-2 consumes many immune"/>
 <result pre="as a reference index in the diagnosis of new SARS-CoV-2" exact="infections" post="in the clinic [29]. Epidemical features It is essential"/>
 <result pre="clinic [29]. Epidemical features It is essential to analyze the" exact="infection" post="source, transmission route, susceptible population and replication rate, especially"/>
 <result pre="source, transmission route, susceptible population and replication rate, especially the" exact="intermediate" post="host and the exact route of transmission, to find"/>
 <result pre="the best measures to prevent the further spread of COVID-19." exact="Infection" post="source The infection sources include patients, virus carriers, and"/>
 <result pre="to prevent the further spread of COVID-19. Infection source The" exact="infection" post="sources include patients, virus carriers, and infected animals that"/>
 <result pre="include patients, virus carriers, and infected animals that serve as" exact="viral" post="reservoirs. Searching for the hosts of the virus, or"/>
 <result pre="Searching for the hosts of the virus, or for the" exact="infection" post="sources, is a vital process in understanding the viral"/>
 <result pre="the infection sources, is a vital process in understanding the" exact="viral" post="dynamics. SARS-CoV-2 has 96.2% genetic sequence similarity to the"/>
 <result pre="and sequence comparison revealed that pangolins are the most likely" exact="intermediate" post="host for SARS-CoV-2 [30]. However, SARS-CoV and MERS-CoV were"/>
 <result pre="bats [9, 32]. Although bat coronaviruses are genetically related, the" exact="intermediate" post="hosts are involved in cross-species transmission, after which human-to-human"/>
 <result pre="after which human-to-human transmission developed. In contrast to SARS-CoV-2, the" exact="intermediate" post="host of SARS-CoV was mainly palm civets [9, 33,"/>
 <result pre="SARS-CoV was mainly palm civets [9, 33, 34], and the" exact="intermediate" post="host of MERS-CoV was thought to be dromedary camels"/>
 <result pre="coronaviruses can be traced to bats, while there are different" exact="intermediate" post="hosts involved in cross-species transmission. These three viruses have"/>
 <result pre="of Peng et al. [5], SARS-CoV-2 can be transmitted through" exact="respiratory" post="droplets and direct contact, confirming that while the main"/>
 <result pre="of SARS and found that SARS was spread mainly by" exact="respiratory" post="droplets [19]. By analyzing case data, Hui et al."/>
 <result pre="transmission routes (long-range airborne, close contact, and fomite), and the" exact="infection" post="risks associated with each hypothesis were estimated using the"/>
 <result pre="available data, all three coronaviruses can be transmitted by breathing" exact="respiratory" post="droplets that contain virions, which indicates that wearing masks"/>
 <result pre="patient age of 39.9â€‰years (range 1â€&quot;91), and the male to" exact="female" post="ratio was 1âˆ¶1.3, with a slight female predominance. MERS-CoV"/>
 <result pre="the male to female ratio was 1âˆ¶1.3, with a slight" exact="female" post="predominance. MERS-CoV had a tendency to affect the elderly"/>
 <result pre="mean age of 56â€‰years (range 14â€&quot;94), and the male to" exact="female" post="ratio was 3.3âˆ¶1 with a male predominance [8, 10,"/>
 <result pre="of SARS is estimated to be 3. Considering that the" exact="disease" post="is now widespread around the world, the R0 of"/>
 <result pre="COVID-19, 4645 deaths and 79â€‰757 cured cases in China. A" exact="total" post="of 5â€‰490â€‰640 cases have been diagnosed, and 346â€‰328 deaths"/>
 <result pre="each administrative region based on data from the Centers for" exact="Disease" post="Control and Prevention and hospitals at all levels. Since"/>
 <result pre="risk communication is becoming an appropriate strategy. There are many" exact="disease" post="control organizations and medical institutions that have played an"/>
 <result pre="cutting off transmission routes mainly by limiting contact and preventing" exact="respiratory" post="droplet transmission. This finding emphasizes the significance of dealing"/>
 <result pre="their feces is an important concern with regard to reducing" exact="viral" post="transmission [36]. On the basis of the research by"/>
 <result pre="structure of ACE2 (PDB code: 6â€‰M17) was obtained from the" exact="Protein" post="Data Bank. The ligands within the crystal structure complex"/>
 <result pre="that COVID-19 has a few similarities with regard to the" exact="infection" post="source and clinical symptoms, but it also some differences."/>
 <result pre="of transmission in common with SARS and MERS, such as" exact="respiratory" post="droplets, but COVID-19 can also be transmitted by the"/>
 <result pre="the general public. The epidemiological research on the source of" exact="infection" post="and the route of transmission could help prevent the"/>
 <result pre="just the common coldJAMA2020323707708 2.TheLEmerging understandings of 2019-nCoVLancet202039531131986259 3.LuHStrattonCWTangYWOutbreak of" exact="pneumonia" post="of unknown etiology in Wuhan China: the mystery and"/>
 <result pre="ChinaLancet20203951022349750631986264 5.ZhouPYangX-LWangX-GHuBZhangLZhangWSiH-RZhuYLiBHuangC-LChenH-DChenJLuoYGuoHJiangR-DLiuM-QChenYShenX-RWangXZhengX-SZhaoKChenQ-JDengFLiuL-LYanBZhanF-XWangY-YXiaoG-FShiZ-LDiscovery of a novel coronavirus associated with the recent" exact="pneumonia" post="outbreak in humans and its potential bat origin2020 6.ChenYLiuQGuoDEmerging"/>
 <result pre="and pathogenesisJ Med Virol202092441842331967327 7.ZhangNWangLDengXLiangRSuMHeCHuLSuYRenJYuFDuLJiangSRecent advances in the detection of" exact="respiratory" post="virus infection in humansJ Med Virol202092440841731944312 8.SongZXuYBaoLZhangLYuPQuYZhuHZhaoWHanYQinCFrom SARS to"/>
 <result pre="pathogenesisJ Med Virol202092441842331967327 7.ZhangNWangLDengXLiangRSuMHeCHuLSuYRenJYuFDuLJiangSRecent advances in the detection of respiratory" exact="virus infection" post="in humansJ Med Virol202092440841731944312 8.SongZXuYBaoLZhangLYuPQuYZhuHZhaoWHanYQinCFrom SARS to MERS, Thrusting"/>
 <result pre="Med Virol202092441842331967327 7.ZhangNWangLDengXLiangRSuMHeCHuLSuYRenJYuFDuLJiangSRecent advances in the detection of respiratory virus" exact="infection" post="in humansJ Med Virol202092440841731944312 8.SongZXuYBaoLZhangLYuPQuYZhuHZhaoWHanYQinCFrom SARS to MERS, Thrusting"/>
 <result pre="the 2019 novel human-pathogenic coronavirus isolated from a patient with" exact="atypical pneumonia" post="after visiting WuhanEmerg Microbes Infect2020922123631987001 15.ZhuNZhangDWangWLiXYangBSongJZhaoXHuangBShiWLuRNiuPZhanFMaXWangDXuWWuGGaoGFTanWA novel coronavirus from"/>
 <result pre="2019 novel human-pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting WuhanEmerg Microbes Infect2020922123631987001 15.ZhuNZhangDWangWLiXYangBSongJZhaoXHuangBShiWLuRNiuPZhanFMaXWangDXuWWuGGaoGFTanWA novel coronavirus from"/>
 <result pre="visiting WuhanEmerg Microbes Infect2020922123631987001 15.ZhuNZhangDWangWLiXYangBSongJZhaoXHuangBShiWLuRNiuPZhanFMaXWangDXuWWuGGaoGFTanWA novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med202038272773331978945 16.HolshueMLDeBoltCLindquistSLofyKHWiesmanJBruceHSpittersCEricsonKWilkersonSTuralADiazGCohnAFoxLPatelAGerberSIKimLTongSLuXLindstromSPallanschMAWeldonWCBiggsHMUyekiTMPillaiSKFirst case of"/>
 <result pre="17.LeiJLiJLiXQiXCT imaging of the 2019 novel coronavirus (2019-nCoV) pneumoniaRadiology20202951832003646 18.HuiDSCZumlaASevere" exact="acute" post="respiratory syndrome: historical, epidemiologic, and clinical featuresInfect Dis Clin"/>
 <result pre="imaging of the 2019 novel coronavirus (2019-nCoV) pneumoniaRadiology20202951832003646 18.HuiDSCZumlaASevere acute" exact="respiratory" post="syndrome: historical, epidemiologic, and clinical featuresInfect Dis Clin North"/>
 <result pre="historical, epidemiologic, and clinical featuresInfect Dis Clin North Am20193386988931668196 19.MonaghanNPEmerging" exact="infections" post="- implications for dental careBritish Dental J201622113 20.SinghSKMiddle East"/>
 <result pre="featuresInfect Dis Clin North Am20193386988931668196 19.MonaghanNPEmerging infections - implications for" exact="dental" post="careBritish Dental J201622113 20.SinghSKMiddle East respiratory syndrome virus pathogenesisSemin"/>
 <result pre="infections - implications for dental careBritish Dental J201622113 20.SinghSKMiddle East" exact="respiratory" post="syndrome virus pathogenesisSemin Respir Crit Care Med20163757257727486737 21.BanikGRKhandakerGRashidHMiddle East"/>
 <result pre="- implications for dental careBritish Dental J201622113 20.SinghSKMiddle East respiratory" exact="syndrome" post="virus pathogenesisSemin Respir Crit Care Med20163757257727486737 21.BanikGRKhandakerGRashidHMiddle East respiratory"/>
 <result pre="respiratory syndrome virus pathogenesisSemin Respir Crit Care Med20163757257727486737 21.BanikGRKhandakerGRashidHMiddle East" exact="respiratory" post="syndrome coronavirus â€œMERS-CoVâ€�: current knowledge gapsPaediatr Respir Rev20151619720226002405 22.XiaoSLiYSungMWeiJYangZA"/>
 <result pre="syndrome virus pathogenesisSemin Respir Crit Care Med20163757257727486737 21.BanikGRKhandakerGRashidHMiddle East respiratory" exact="syndrome" post="coronavirus â€œMERS-CoVâ€�: current knowledge gapsPaediatr Respir Rev20151619720226002405 22.XiaoSLiYSungMWeiJYangZA study"/>
 <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version)Mil Med Res20207432029004 24.PangJWangMXAngIYHTanSHXLewisRFChenJIGutierrezRAGweeSXWChuaPEYYangQNgXYYapRKTanHYTeoYYTanCCCookARYapJCHsuLYPotential rapid diagnostics, vaccine and"/>
 <result pre="Med20209623 25.YongCYOngHKYeapSKHoKLTanWSRecent advances in the vaccine development against Middle East" exact="respiratory" post="syndrome-coronavirusFront Microbiol201910178131428074 26.ModjarradKRobertsCCMillsKTCastellanoARPaolinoKMuthumaniKReuschelELRobbMLRacineTOhMDLamarreCZaidiFIBoyerJKudchodkarSBJeongMDardenJMParkYKScottPTRemigioCParikhAPWiseMCPatelADuperretEKKimKYChoiHWhiteSBagarazziMMayJMKaneDLeeHKobingerGMichaelNLWeinerDBThomasSJMaslowJNSafety and immunogenicity of an anti-Middle East"/>
 <result pre="respiratory syndrome-coronavirusFront Microbiol201910178131428074 26.ModjarradKRobertsCCMillsKTCastellanoARPaolinoKMuthumaniKReuschelELRobbMLRacineTOhMDLamarreCZaidiFIBoyerJKudchodkarSBJeongMDardenJMParkYKScottPTRemigioCParikhAPWiseMCPatelADuperretEKKimKYChoiHWhiteSBagarazziMMayJMKaneDLeeHKobingerGMichaelNLWeinerDBThomasSJMaslowJNSafety and immunogenicity of an anti-Middle East" exact="respiratory" post="syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm,"/>
 <result pre="syndrome-coronavirusFront Microbiol201910178131428074 26.ModjarradKRobertsCCMillsKTCastellanoARPaolinoKMuthumaniKReuschelELRobbMLRacineTOhMDLamarreCZaidiFIBoyerJKudchodkarSBJeongMDardenJMParkYKScottPTRemigioCParikhAPWiseMCPatelADuperretEKKimKYChoiHWhiteSBagarazziMMayJMKaneDLeeHKobingerGMichaelNLWeinerDBThomasSJMaslowJNSafety and immunogenicity of an anti-Middle East respiratory" exact="syndrome" post="coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751332007143 30.JiWWangWZhaoXZaiJLiXHomologous recombination within"/>
 <result pre="Reservoir for Potential Novel CoronavirusesViruses201911423 32.HuiDSEpidemic and emerging coronaviruses (Severe" exact="Acute" post="Respiratory Syndrome and Middle East Respiratory Syndrome)Clin Chest Med201738718628159163"/>
 <result pre="for Potential Novel CoronavirusesViruses201911423 32.HuiDSEpidemic and emerging coronaviruses (Severe Acute" exact="Respiratory" post="Syndrome and Middle East Respiratory Syndrome)Clin Chest Med201738718628159163 33.Al-TawfiqJAZumlaAMemishZATravel"/>
 <result pre="Potential Novel CoronavirusesViruses201911423 32.HuiDSEpidemic and emerging coronaviruses (Severe Acute Respiratory" exact="Syndrome" post="and Middle East Respiratory Syndrome)Clin Chest Med201738718628159163 33.Al-TawfiqJAZumlaAMemishZATravel implications"/>
 <result pre="and emerging coronaviruses (Severe Acute Respiratory Syndrome and Middle East" exact="Respiratory" post="Syndrome)Clin Chest Med201738718628159163 33.Al-TawfiqJAZumlaAMemishZATravel implications of emerging coronaviruses: SARS"/>
 <result pre="and automated, sample-in to result-out, system for nanotechnology-based detection of" exact="infectious" post="pathogensNanoscience and Nanotechnology Letters20181014231428 35.CrameriGDurrPABarrJYuMGrahamKWilliamsOJKayaliGSmithDPeirisMMackenzieJSWangLFAbsence of MERS-CoV antibodies in"/>
 <result pre="ModelsAnimal Model Exp Med2018112513330891557 43.RothanHAByrareddySNThe epidemiology and pathogenesis of coronavirus" exact="disease" post="(COVID-19) outbreakJ Autoimmun202010910243332113704 44.HellewellJAbbottSGimmaABosseNIJarvisCIRussellTWMundayJDKucharskiAJEdmundsWJFunkSEggoRMFeasibility of controlling COVID-19 outbreaks by"/>
 <result pre="Health20208e488e49632119825 45.HusnayainAFuadASuECApplications of google search trends for risk communication in" exact="infectious disease" post="management: a case study of COVID-19 outbreak in TaiwanInt"/>
 <result pre="45.HusnayainAFuadASuECApplications of google search trends for risk communication in infectious" exact="disease" post="management: a case study of COVID-19 outbreak in TaiwanInt"/>
 <result pre="J Infect Dis20209522122332173572 46.Kamel BoulosMNGeraghtyEMGeographical tracking and mapping of coronavirus" exact="disease" post="COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and"/>
 <result pre="Dis20209522122332173572 46.Kamel BoulosMNGeraghtyEMGeographical tracking and mapping of coronavirus disease COVID-19/severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events"/>
 <result pre="46.Kamel BoulosMNGeraghtyEMGeographical tracking and mapping of coronavirus disease COVID-19/severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around"/>
 <result pre="BoulosMNGeraghtyEMGeographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) epidemic and associated events around the"/>
 <result pre="and epidemiological characteristics of 34 children with 2019 novel coronavirus" exact="infection" post="in ShenzhenZhonghua Er Ke Za Zhi202058E00832062875 49.PradhanPPandeyAKMishraAGuptaPTripathiPKMenonMBGomesJVivekanandanPKunduBUncanny similarity of"/>
</results>
